MicroRNAs: Following a single 4-hour HP treatment, decreases were observed in seven out of ten miRNAs examined in two of the three participants. MicroRNAs are one component of the cargo of ...

said James (Jim) Frakes, CEO and CFO of Aethlon Medical. In the initial three patients, there were encouraging changes in ...

Recent clinical trial update news from Aethlon Medical, Inc. (NASDAQ: AEMD), Envoy Medical, Inc. (NASDAQ: COCH), Soligenix, ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking ...

Recent clinical trial update news from Aethlon Medical, Inc. ( Nasdaq: AEMD ), Envoy Medical, Inc. ( Nasdaq: COCH ), ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...

Vitamin B6 helps your body convert food into energy, keeps your immune system strong, and may improve heart health.

Your immune system is a network of cells, tissues, and organs that fight off infection. Your immune system can be affected by ...

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.